The global lipid nanoparticle manufacturing market is estimated to be worth USD 0.66 billion in 2023. Driven by the increasing need for novel LNP formulation, along with the ongoing advancements in ...
Malvern Panalytical’s recent peer-reviewed publication, Tailoring Lipid Nanoparticle Dimensions Through Manufacturing Processes, published in RSC Pharmaceutics, features both the NanoSight Pro ...
JERSEY, NJ, US, March 26, 2024 /EINPresswire.com/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nanoparticle ...
For patients with certain types of cancer, CAR T cell therapy has been nothing short of life changing. Developed in part by Carl June, Richard W. Vague Professor at Penn Medicine, and approved by the ...
Lipid-based nanoparticles (LNPs) are becoming an essential platform in pharmaceutical research and manufacturing. They’re used to improve the delivery of mRNA, enhance the absorption of poorly ...
Characterizing oligonucleotide aggregates is increasingly necessary as large nucleic acids and lipid nanoparticles (LNP) move beyond the lab and into production. Unfortunately, existing technologies ...
The results not only underscore the robustness of our nanoparticle manufacturing process but also pave the way for future advancements in drug delivery systems.” Recognizing critical gaps in reliable ...
This new eBook from Inprocess LSP shows how to overcome these bottlenecks with real-time, continuous particle size analysis. It offers practical guidance on enhancing process control, accelerating ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
Lipid nanoparticles consist of spherical vesicles made of ionizable lipids with a positive charge at a low pH level, while being neutral at a physiological pH. Such a characteristic enables RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback